Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies

Elife. 2021 Apr 19:10:e65005. doi: 10.7554/eLife.65005.

Abstract

The HIV-1 gp120/gp41 trimer undergoes a series of conformational changes in order to catalyze gp41-induced fusion of viral and cellular membranes. Here, we present the crystal structure of gp41 locked in a fusion intermediate state by an MPER-specific neutralizing antibody. The structure illustrates the conformational plasticity of the six membrane anchors arranged asymmetrically with the fusion peptides and the transmembrane regions pointing into different directions. Hinge regions located adjacent to the fusion peptide and the transmembrane region facilitate the conformational flexibility that allows high-affinity binding of broadly neutralizing anti-MPER antibodies. Molecular dynamics simulation of the MPER Ab-stabilized gp41 conformation reveals a possible transition pathway into the final post-fusion conformation with the central fusion peptides forming a hydrophobic core with flanking transmembrane regions. This suggests that MPER-specific broadly neutralizing antibodies can block final steps of refolding of the fusion peptide and the transmembrane region, which is required for completing membrane fusion.

Keywords: 2H10; 4E10; HIV-1; LN01; gp41; infectious disease; membrane fusion; microbiology; molecular biophysics; structural biology; virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Specificity
  • Binding Sites, Antibody
  • Broadly Neutralizing Antibodies / immunology
  • Broadly Neutralizing Antibodies / metabolism*
  • HEK293 Cells
  • HIV Antibodies / immunology
  • HIV Antibodies / metabolism*
  • HIV Envelope Protein gp41 / antagonists & inhibitors*
  • HIV Envelope Protein gp41 / immunology
  • HIV Envelope Protein gp41 / metabolism
  • HIV-1 / immunology*
  • Humans
  • Lipid Bilayers
  • Membrane Fusion
  • Molecular Dynamics Simulation
  • Protein Binding
  • Protein Conformation
  • Protein Folding
  • Protein Stability
  • Single-Domain Antibodies / immunology
  • Single-Domain Antibodies / metabolism*
  • Structure-Activity Relationship

Substances

  • Broadly Neutralizing Antibodies
  • HIV Antibodies
  • HIV Envelope Protein gp41
  • Lipid Bilayers
  • Single-Domain Antibodies

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.